CATALOGO DEI PRODOTTI DELLA RICERCA

ZANOTTI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.927
EU - Europa 4.755
AS - Asia 3.458
SA - Sud America 404
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 79
OC - Oceania 18
Totale 14.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.817
RU - Federazione Russa 1.647
SG - Singapore 1.230
CN - Cina 1.210
GB - Regno Unito 1.115
IT - Italia 457
SE - Svezia 347
VN - Vietnam 305
BR - Brasile 300
DE - Germania 272
HK - Hong Kong 252
FR - Francia 236
IE - Irlanda 207
FI - Finlandia 199
BD - Bangladesh 109
KR - Corea 98
CA - Canada 63
UA - Ucraina 54
NL - Olanda 50
IN - India 48
AR - Argentina 36
TR - Turchia 36
JP - Giappone 34
BE - Belgio 33
PL - Polonia 29
ID - Indonesia 28
ES - Italia 25
MX - Messico 22
ZA - Sudafrica 21
AT - Austria 19
NG - Nigeria 19
AU - Australia 16
EC - Ecuador 14
IQ - Iraq 14
VE - Venezuela 14
UZ - Uzbekistan 13
CL - Cile 12
CO - Colombia 10
PK - Pakistan 10
MA - Marocco 9
MY - Malesia 9
LT - Lituania 8
CH - Svizzera 7
DK - Danimarca 7
BO - Bolivia 6
CZ - Repubblica Ceca 6
IR - Iran 6
RO - Romania 6
TN - Tunisia 6
AZ - Azerbaigian 5
GR - Grecia 5
PE - Perù 5
PY - Paraguay 5
CR - Costa Rica 4
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
BJ - Benin 3
HR - Croazia 3
JM - Giamaica 3
NO - Norvegia 3
NP - Nepal 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CG - Congo 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
Totale 14.624
Salva come PNG Salva come JPEG
Città #
Southend 928
Ashburn 883
Singapore 648
Moscow 570
San Jose 512
Chandler 511
Dallas 443
Jacksonville 322
Woodbridge 305
Ann Arbor 293
Beijing 292
Hong Kong 249
Dublin 205
Houston 166
The Dalles 155
Council Bluffs 152
New York 148
Verona 133
Wilmington 108
Los Angeles 92
Jinan 88
Ho Chi Minh City 85
Lawrence 80
Princeton 80
Hanoi 74
Nanjing 65
Munich 58
Helsinki 57
Shenyang 55
São Paulo 45
Bologna 42
Santa Clara 42
Tianjin 41
Hebei 39
Columbus 38
Buffalo 37
Ningbo 34
Brussels 33
Milan 32
Changsha 31
Tokyo 31
Zhengzhou 31
Denver 29
Hangzhou 29
Taizhou 29
Boardman 28
Haikou 28
Chicago 27
Guangzhou 27
Redondo Beach 26
Manchester 25
Atlanta 24
Turku 24
Seattle 23
Warsaw 23
Groningen 22
Chennai 21
Nanchang 21
Sindelfingen 21
Rome 20
Frankfurt am Main 19
Montreal 19
Norwalk 18
Jiaxing 17
Orem 17
London 16
Phoenix 16
Stockholm 16
Taiyuan 16
Toronto 16
Dearborn 15
Redwood City 15
Seoul 15
Vienna 15
Abuja 14
Brooklyn 14
Haiphong 14
Johannesburg 14
Lancaster 14
Boston 13
Falls Church 13
San Francisco 13
Tashkent 12
Amsterdam 11
Dong Ket 11
Falkenstein 11
Jakarta 11
Washington 11
Fuzhou 10
Lanzhou 10
Mexico City 10
Poplar 10
Augusta 9
Biên Hòa 9
Charlotte 9
Shanghai 9
Turin 9
Belo Horizonte 8
Düsseldorf 8
Fairfield 8
Totale 9.195
Salva come PNG Salva come JPEG
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 352
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 277
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 273
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 267
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 264
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 264
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 257
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 248
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 247
BCR-signaling profiles associated with prognosis and progression in B-CLL 245
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 239
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 237
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 232
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 231
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 230
BCR-signaling profiles associated with prognosis and progression in B-CLL 228
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 225
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 223
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 221
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 217
Bone involvement and osteoporosis in mastocytosis. 214
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 214
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 212
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 206
Bone involvement in patient with clonal mast cell disorders 205
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 198
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 196
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 195
Underdiagnosed systemic mastocytosis: The role of flow cytometry 192
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 192
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 192
The high oxygen affinity haemoglobin Nantes: a family case description 191
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 189
Osteopetrosi 185
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 183
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 181
Bone Disease in Mastocytosis 180
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 175
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 174
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 174
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 174
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 173
Prevalence of osteoporosis in patients affected by mastocytosis 172
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 170
Ultra-deep sequencing (UDS) allows more sensitive detection of the D816V and other KIT gene mutations in systemic mastocytosis 170
Effects of denosumab on peripheral lymphocyte subpopulations 168
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 167
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 164
Vaccination Management In Children and Adults With Mastocytosis 164
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 163
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry 161
Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association 154
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 153
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 152
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 152
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 151
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 149
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 149
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study 149
Male osteoporosis and hymenoptera venom anaphylaxis [Osteoporosi maschile e anafilassi da imenotteri] 142
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 142
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 142
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 140
Single Cell Network Profiling (SCNP) assay reveals B Cell Receptor Signaling heterogeneity in the Context of ZAP-70 Expression in patients with Chronic Lymphocytic Leukemia (CLL) 140
Mastocytosis and allergic diseases 140
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 136
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 135
Systemic Mastocytosis 134
Skeletal implications of isolated bone marrow mastocytosis (reply): Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis (reply) 133
Mast Cell Disorders In Drug Hypersensitivity 132
Rapid skeletal turnover in radiographic mimic of osteopetrosis might be secondary to systemic mastocytosis [corrected] 126
Hymenoptera Allergy and Mast Cell Activation Syndromes 125
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives 109
Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. 108
Mastocytosis and insect venom allergy 106
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM 103
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 103
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 102
Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study 91
Night shift work and lymphoma: results from an Italian multicentre case-control study 76
Letter to the Editor: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis 73
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 55
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 54
null 44
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 33
Occupational exposure to formaldehyde and risk of lymphoma subtypes: results of a multicentre Italian case-control study 30
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM 12
Totale 14.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.215
article - articoli 33.118
book - libri 0
conference - conferenze 14.097
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022444 0 0 0 91 42 19 21 42 35 22 39 133
2022/20231.442 92 170 114 292 92 362 30 76 163 10 26 15
2023/2024773 57 66 47 69 88 132 37 71 5 39 123 39
2024/20251.771 85 126 98 300 80 47 78 62 287 124 160 324
2025/20265.619 379 301 405 897 1.362 376 508 276 444 359 168 144
2026/2027957 90 157 268 442 0 0 0 0 0 0 0 0
Totale 14.746